Whitehawk Therapeutics, Inc. (WHWK) News
Follow Whitehawk Therapeutics, Inc. (WHWK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
WHWK - Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
WHWK - Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
NEWS | Sep 14, 2026, 01:31 AM UTC
L
Whitehawk Therapeutics appoints Vijay Iyengar to board
Whitehawk Therapeutics said Vijay Iyengar was appointed as a Class III director, effective September 9, 2026. The item cites an original SEC filing.
EQUITY | Sep 10, 2026, 09:04 PM UTC
L
Whitehawk Therapeutics appoints Vijay Iyengar to board of directors
EQUITY | Sep 10, 2026, 08:11 PM UTC
L
Whitehawk Therapeutics appoints Vijay Iyengar, MD, to board
EQUITY | Sep 10, 2026, 08:06 PM UTC
L
Whitehawk Therapeutics appoints Vijay Iyengar to its board
Whitehawk Therapeutics, Inc. says it has appointed Vijay Iyengar, MD, to its board of directors.
EQUITY | Sep 10, 2026, 08:05 PM UTC
L
WHWK - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
WHWK - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
EQUITY | Sep 02, 2026, 12:00 PM UTC
L
WHWK WHWK - Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
WHWK WHWK - Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
EARNINGS | Aug 06, 2026, 12:02 PM UTC